These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 668390)

  • 41. Bound amino acids in uremic sera: search for peptidic middle molecules by preparative polyacrylamide gel electrophoresis and high performance liquid chromatography.
    Kaplan B; Gotfried M; Cojocaru M; Pras M; Ravid M
    Clin Chim Acta; 1989 Nov; 185(2):119-30. PubMed ID: 2624993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. II. Chief peptide constituents of the faction.
    Klein A; Sarnecka-Keller M; Hanicki Z
    Clin Chim Acta; 1978 Nov; 90(1):7-11. PubMed ID: 719891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Many hitherto unknown peptides are principal constituents of uremic "middle molecules".
    Menyhárt J; Gróf J
    Clin Chem; 1981 Oct; 27(10):1712-6. PubMed ID: 7285323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and identification of L-beta-aspartyl-Llysine and L-gamma-glutamyl-L-ornithine from normal human urine.
    Lou MF
    Biochemistry; 1975 Jul; 14(15):3503-8. PubMed ID: 1148212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.
    Powell DR; Rosenfeld RG; Baker BK; Liu F; Hintz RL
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1186-92. PubMed ID: 3760118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of N-beta-L-aspartyl-L-phenylalanine as a normal constituent of human plasma and urine.
    Burton EG; Schoenhard GL; Hill JA; Schmidt RE; Hribar JD; Kotsonis FN; Oppermann JA
    J Nutr; 1989 May; 119(5):713-21. PubMed ID: 2723819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An aminopeptidase from mouse brain cytosol that cleaves N-terminal acidic amino acid residues.
    Kelly JA; Neidle EL; Neidle A
    J Neurochem; 1983 Jun; 40(6):1727-34. PubMed ID: 6854330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study of middle molecules with positive reaction to ninhydrin present in uremic and normal blood and their isolation].
    Buzio C; Dall'Aglio PP; Delmonte G; Montagna G; Migone L
    Minerva Nefrol; 1979; 26(1):45-8. PubMed ID: 471320
    [No Abstract]   [Full Text] [Related]  

  • 49. Chromogranin A in uremia: progressive retention of immunoreactive fragments.
    Hsiao RJ; Mezger MS; O'Connor DT
    Kidney Int; 1990 Mar; 37(3):955-64. PubMed ID: 2313983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluid secretion in isolated proximal straight renal tubules. Effect of human uremic serum.
    Grantham JJ; Irwin RL; Qualizza PB; Tucker DR; Whittier FC
    J Clin Invest; 1973 Oct; 52(10):2441-50. PubMed ID: 4738063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
    J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function.
    Periyasamy SM; Chen J; Cooney D; Carter P; Omran E; Tian J; Priyadarshi S; Bagrov A; Fedorova O; Malhotra D; Xie Z; Shapiro JI
    Kidney Int; 2001 Dec; 60(6):2367-76. PubMed ID: 11737612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and quantification of a protein-bound ligand in uremic serum.
    Takeda N; Niwa T; Tatematsu A; Suzuki M
    Clin Chem; 1987 May; 33(5):682-5. PubMed ID: 3568353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P; Monti JP; Crevat A; Durand C; Murisasco A
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone.
    Arieff AI; Massry SG
    J Clin Invest; 1974 Feb; 53(2):387-92. PubMed ID: 11344551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The hydrolysis of beta-aspartyl peptides by rat tissue.
    Dorer FE; Haley EE; Buchanan DL
    Arch Biochem Biophys; 1968 Sep; 127(1):490-5. PubMed ID: 5697999
    [No Abstract]   [Full Text] [Related]  

  • 58. Demonstration of a low-molecular-weight natriuretic factor in uremic serum.
    Bourgoignie JJ; Weisser F; Rolf D; Klahr S; Bricker NS
    Trans Assoc Am Physicians; 1970; 83():277-87. PubMed ID: 5505394
    [No Abstract]   [Full Text] [Related]  

  • 59. The presence of a natriuretic factor in urine of patients with chronic uremia. The absence of the factor in nephrotic uremic patients.
    Bourgoignie JJ; Hwang KH; Ipakchi E; Bricker NS
    J Clin Invest; 1974 Jun; 53(6):1559-67. PubMed ID: 4830222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colorimetry of serum acetaminophen (paracetamol) in uremia.
    Bailey DN
    Clin Chem; 1982 Jan; 28(1):187-90. PubMed ID: 7055909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.